🟢 Nutex Health is trading 8.2% up today in after-hours trading after substantially exceeding second-quarter expectations

Nutex Health is trading at $164.37, up 8.19% now in after-hours trading after second-quarter 2026 results substantially exceeded expectations.

• Net income reached $65.8 million, or $9.38 diluted EPS, versus a prior-year loss; revenue totaled $210.8 million.
• Profitability was attributed to operational efficiencies and sharply lower arbitration-related expenses; revenue fell 13.6% year over year, while first-half net income reached $112.6 million.
• Management will discuss results on the August 7, 2026 conference call; broader markets finished modestly lower.